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Abstract  
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) addresses the urgent need 
for data on diabetes prevalence, risk factors and associated conditions in Australia. Here we 
describe the methods used and the response rates obtained. AusDiab is a population-based 
cross-sectional survey of national diabetes mellitus prevalence and associated risk factors in 
people aged ≥25 years, conducted between May 1999 and December 2000 in the 6 states and 
the Northern Territory of Australia. The study involved an initial household interview, 
followed by a biomedical examination that included an oral glucose tolerance test (OGTT), 
standard anthropometric tests, blood pressure measurements and the administration of 
questionnaires. Of the 20,347 eligible people (aged ≥ 25 years and resident at the address for 
≥6 months) who completed a household interview, 11,247 (55.3%) attended for the 
biomedical examination. Of those who completed the biomedical examination 55.1% were 
female. Comparisons with the 1998 Australian population estimates showed that younger 
age responders were under-represented at the biomedical examination, while the middle-
aged and older age groups were over-represented. Weighting of the AusDiab data for age 
and gender have corrected for this bias. AusDiab, which is the largest national diabetes 
prevalence study undertaken in a developed nation to have used an OGTT, provides a 
valuable national resource for the study of the prevalence and possible causes of diabetes, as 
well as identifying possible risk factors that may lead to diabetes. Furthermore, it generates 
the baseline data for a prospective 5-year cohort study. The data will be important for 
national and regional public health and lifestyle education and health promotion programs. 
Key Words: AusDiab; response rates; diabetes survey; Australia; diabetes prevalence.
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1. Introduction 
Globally, the prevalence of diabetes, particularly Type 2 diabetes is rapidly increasing [1]. 
Indeed, it has been predicted that the global figure of people with diabetes will rise from 
current levels of about 150 million in 2000 to 300 million by 2025 [2]. However, with the 
exception of the USA [3], nationally representative, population based diabetes prevalence 
data among developed nations is scarce. In particular, few studies have involved an oral 
glucose tolerance test (OGTT). 
 
In Australia, estimates of diabetes prevalence and other categories of glucose intolerance are 
confined to studies conducted 10 to 20 years ago on a small sample of residents from a rural 
town in Western Australia [4]. Most recent estimates of diabetes prevalence in Australia 
have relied on self-reported data, but since Type 2 diabetes can be asymptomatic for many 
years before it is diagnosed in a clinical situation, reliance on self-reported information 
invariably contributes to an underestimation of the true prevalence. Furthermore, such 
studies fail to provide information on the extent of other states of glucose intolerance, which 
are known to substantially increase risk of future diabetes. 
 
To address the urgent need for more definitive data on the true current prevalence of 
diabetes and its associated risk factors in Australia, the Australian Diabetes, Obesity and 
Lifestyle Study (AusDiab) was a cross-sectional study involving a standard OGTT 
conducted during 1999-2000 in all Australian States and the Northern Territory. The present 
paper provides a detailed description of the survey methods including the design, sampling 
techniques and survey protocols. Data on weighting of the sample, response rates and 
statistical techniques are also presented. The survey methods conform to those 
recommended by the World Health Organisation (WHO) [5], and the study was approved by 
the International Diabetes Institute ethics committee. 
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The AusDiab study aimed to determine the national prevalence of diabetes and other 
selected non-communicable diseases and their risk factors in a representative sample of 
adults aged 25 years and over from each of the states and the Northern Territory of 
Australia.  
More specifically, the objectives of the study were: 
1. to estimate the national and regional prevalence of diabetes and other forms of 
abnormal glucose tolerance 
2. to estimate the prevalence of the cardiovascular risk factors within the Metabolic 
Syndrome, including obesity, hypertension, and lipid profile abnormalities 
3. to assess the distribution and relationships of the cardiovascular risk factors indicated 
above 
4. to assess temporal trends in risk factor prevalences with reference to previous 
Australian surveys 
5. to describe health knowledge and attitudes and utilization of health services, and 
6. to provide baseline data for longitudinal cohort studies 
 
2. Methods 
2.1 Target population/Eligibility requirements 
Non-institutionalised adults aged 25 years and over residing in private dwellings in each of 
the 6 states and the Northern Territory of Australia were included in the survey if they had 
resided permanently at the address for a minimum of six months prior to the survey. Persons 
with physical or intellectual disabilities that precluded participation in the study were not 
included.  
2.2 Sampling frame 
A stratified cluster sampling method was used, involving seven strata (six states and the 
Northern Territory) and clusters based on Census Collector Districts (CDs – the smallest 
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geographic unit defined by the Australian Bureau of Statistics at each census, with an 
average of 225 dwellings each). Within each state, six CDs were randomly selected with a 
selection probability proportional to the population size (population aged over 25 years). 
Due to the logistic and economic constraints of the survey, and to avoid the bias of including 
an unrepresentative number of high prevalence groups, the following exclusion criteria were 
adopted: 
1. CDs containing fewer than 100 persons aged 25 years and over 
2. CDs that formed part of a Statistical Local Area (SLA) that was classified as 100% rural 
according to 1996 census data [6] 
3. CDs that contained more than 10% indigenous population 
 
Of the total pool of CDs available (34,410), 4141 CDs (12%) were excluded from selection 
on these grounds. From the excluded CD’s, 762 (18.4%) had >10% indigenous population, 
1464 (35.4 %) were rural, 1100 (26.6%) had <100 persons aged ≥25 years, while 815 
(19.7%) had more than one factor of the exclusion criteria. The three exclusion categories 
meant that the total eligible population (adults aged ≥25 years) was reduced by 6.44% from 
11,341,070 to 10,610,855. This comprised 241,931 (33.1%) adults from CDs that had >10% 
indigenous population, 349,716 (47.9%) adults from CDs that were rural, 74,723 (10.2%) 
adults from CDs that had <100 people aged ≥25 years and 63,845 (8.7%) adults from CDs 
that had more than one factor of the exclusion criteria. 
 
2.3 Sample size determination  
The sample size was selected based on precision of estimates to identify a national diabetes 
prevalence of 7.0% (an estimation based on results of previous surveys, and the expectation 
that the diabetes rate had increased over time). As a secondary objective of the study was to 
deliver useful state-specific prevalence estimates, the sampling frame was stratified at the 
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state level. With very little loss of efficiency, an accurate national estimate can be obtained 
from weighted samples of equal size from the six states and the Northern Territory. 
Accounting for the clustering of the survey design, a sample size of 10,500 (1500 per state) 
was predicted to provide 95% confidence intervals of 6.2 – 7.8, around a diabetes estimate 
of 7.0%. This level of precision was regarded as acceptable, and the sample size was 
considered achievable and within the funding constraints of the survey. It should be noted 
however, that the sample size was calculated for total diabetes prevalence only and would be 
expected to have limited power to describe the prevalence of type 1 diabetes in this sample. 
 
2.4 Sample selection 
It was calculated that six CDs were required to provide the required sample size (1500 per 
state) within each state. Following an initial field visit, if the CD was considered 
inappropriate for sampling in that location, the selected CD was replaced with another 
randomly selected CD from the same state. Replacements occurred in seven instances during 
the course of the survey, for the following reasons:  
 
1. The low population density of the CD made it economically and logistically impossible to 
conduct the survey activities within the allocated timeframe (3 CDs) 
2. The area selected was predominantly an industrial/business zone (2CDs) 
3. No eligible ‘neighbouring’ CD was available (see below) (1CD) 
4. The area had been recently involved in a large-scale health survey, including diabetes 
testing (1CD) 
 
After the first three sites had been surveyed, it became clear that a single CD would not 
provide the required sample size at each location surveyed. Clusters were subsequently 
formed by combining the randomly selected index CD and its largest adjoining neighbours 
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to achieve a minimum cluster size of 250 participants. The final sample comprised 3 single 
CDs, 22 pairs of CDs, 16 triplets and 1 quad.  
 
2.5 Survey protocol and procedures 
The AusDiab survey activities occurred over a 21-month period between May 1999 and 
December 2001. Approximately 2 months were allocated to the collection of data in each 
state and the Northern Territory. The AusDiab survey activities were divided into two 
phases – the household interview and the biomedical examination. 
 
2.5.1 Household census and interview 
Following a local media advertising campaign involving news items in local community 
newspapers and local radio and/or television, all private dwellings within the sampled 
cluster received a hand-delivered (non-addressed) letter informing residents about the survey 
and advising that an AusDiab interviewer would visit to conduct the household interview. A 
brochure describing the study objectives, the interview and examination process, and study 
confidentiality was supplied in the initial contact letter. This brochure was provided only in 
English. 
 
The first visit by the interviewer occurred approximately 3 days after the letter had been 
delivered. If the interviewer could not make contact with household members, a letter was 
left requesting the household to telephone a toll-free number to arrange a suitable interview 
time. The interviewers made a minimum of 2 visits and up to 5 visits before a household 
was classified as a non-contact.  
 
Where possible, at each participating household a personal interview was conducted with 
every adult member aged 25 years and over who met the eligibility requirements. The 
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interview ascertained marital status, level of education, date and country of birth, language 
spoken at home and history of diabetes or high blood sugar levels. In some instances, adult 
household members were unable to answer for themselves because of old age, illness, 
intellectual disability or difficulty with the English language. In these cases, a responsible 
‘proxy’ was interviewed on their behalf. There were no provisions for interviews to be 
conducted in languages other than English. In order to obtain a personal interview with all 
eligible household members, interviewers made appointments to visit as often as was 
necessary to the household. In a small number of cases interviews were conducted over the 
telephone with the Household Survey Coordinator.  
 
At the completion of the interview, all household members aged 25 years or older were 
invited to attend a local testing site for the biomedical examination. Participants were 
provided with a brochure explaining the biomedical examination procedures, together with 
the self-administered SF-36 General Health and Well-Being questionnaire, which they were 
asked to complete and bring to their biomedical examination appointment.  
 
2.5.2 Biomedical examination 
The biomedical examination was conducted at a local test site on weekdays (except Friday) 
and weekend days over an 8-day period in each sampled area. Local survey sites included 
community centres, scout headquarters, sporting venues, church halls and schools. Survey 
activities at the testing site commenced at 7:00 a.m. and typically finished at 2:00 p.m. On 
average, approximately 40 participants attended daily. 
 
All responders gave written informed consent to participate in the survey upon arrival at the 
testing site. The AusDiab biomedical examination protocol followed closely the WHO 
recommended model for diabetes and other non-communicable disease field surveys [5, 7]. 
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The components of the biomedical examination are shown in Table 1. Following the initial 
collection of the fasting blood sample, an oral glucose tolerance test (OGTT) was performed 
on all participants, except those on insulin or oral hypoglycaemic drugs or those who were 
pregnant. The OGTT was performed according to World Health Organization (WHO) 
specifications. Participants moved through the biomedical examination procedures in a 
circuit-like manner that took approximately 2.5 to 3 hours to complete. The SF-36 and 
dietary questionnaires were self-administered, while all other questionnaires were 
interviewer administered. All data from the participant record forms were entered both 
electronically and manually.  
 
3. Results 
3.1 Survey Response 
Response rates to the household interview and the biomedical examination are shown in 
Figure 1. In total, the AusDiab interviewers approached 25,984 households in the 42 
selected clusters. Of these, 6,769 (26%) were classified as non-contacts. Reasons for non-
contact (and hence non-participation) in the household interview included language 
difficulties (318 households), no access gained to the residence (e.g. because of dangerous 
dogs, security fences) (941), the householders not being contactable despite several attempts 
(5358), and other reasons such as drunkenness or disability of the householders (152).  
 
Of the 19,215 residential properties where contact was achieved, 1095 were excluded 
because none of the occupants met the residency criteria of the survey, and a further 991 
were excluded because all of the residents in the household were less than 25 years of age. 
Of the remaining 17,129 eligible households, 5,178 refused to be interviewed and 472 were 
away for the duration of the study period, giving rise to a total of 11,479 households (70.2%) 
where an interview was achieved. Reasons for refusal included health concerns (486, 9.4%), 
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being unable to attend because of work commitments (1,159, 22.4%), feeling they were too 
old to participate (368, 7.1%), medical problems (1,317, 25.4%), and “other” reasons (1,848, 
35.7%). 
 
Assuming that the proportion of ineligible households was similar between the contacted 
(2,086/19,215 = 10.9% ineligible) and the non-contacted households, 49.6% 
(11,479/23,163) of eligible households participated in the household interview. The 
denominator here (23,163) is calculated as all private dwellings (25,984) minus all ineligible 
households (2,821, which is comprised of 2,086 contacted ineligible households, plus 735, 
which is an equivalent percentage of non-contacted ineligible households). This response 
rate is a conservative estimate, as more of the non-contacted households are likely to be 
unoccupied or have fewer occupants than contacted households.  
 
In the 17,129 households that were confirmed as containing at least one eligible participant, 
20,347 eligible adults were interviewed. Of those who participated in the household 
interview, 11,247 (55.3%) took part in the biomedical examination. This response rate for 
the biomedical examination ranged from 49.5% in Queensland and 49.6% in South Australia 
to 61.8% in Western Australia (Table 2). Assuming that the numbers of eligible adults 
residing in the 5,178 households that refused the household interview was the same as in 
those which participated, and combining the household response rate (11,479/17,129 – 67%) 
with the biomedical examination response rate (11,247/20,347 – 55.3%) the overall response 
rate can be estimated to be 37%. 
 
3.2 Profile of responders & weighting of the survey sample 
To account for the clustering and stratification of the survey design, and to adjust for non-
response, the data have been weighted to match the age and gender distribution of the 1998 
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estimated residential population of Australia aged over 25 years [8]. The weighting factor is 
based on the probability of selection in each cluster. The number of males and females in 
each cluster aged 25 years and over identified in the 1996 Census was used to calculate the 
probability of selection in each cluster. The weight was then calculated based on the 
probability of selection, adjusted to reflect the age and sex structure of the 1998 estimated 
residential population over the age of 25. Groups based on age deciles and gender defined 
the weighting variable. As there are two distinct populations in our sample – one who 
participated in the household interview and a subset of this population who attended the 
biomedical examination, two weighting factors have been applied, one to all responders to 
the biomedical examination and another to all responders to the household interview. 
 
Among the responders to the biomedical examination (n=11,247), 44.9% were male, with 
the mean age being 51.5 years (Table 3). This compares to 49.0% male in the 1998 
Australian population, and a mean age in the 1996 census [6] over 25 years of 48.1 years. 
Among the non-responders (n=9,049), 51.2% were male and the mean age was 47.7 years. 
Weighting of the sample to the estimated 1998 residential Australian population corrected 
the gender and age bias, with 49.0% (95% CI, 47.9 - 50.1) of the weighted responders to the 
biomedical examination being male, and the mean age being 48.2 years (95% CI, 46.6-49.9).  
 
Table 3 provides a comparison between responders and non-responders to the biomedical 
examination for both unweighted and gender and age-adjusted estimates, with respect to 
various demographic characteristics. For the crude, unadjusted estimates, significant 
differences were observed for percent married, the percentage of English speaking 
participants, the percent born in the United Kingdom (UK), and the percentage who 
suspected they had diabetes, but no differences were noted for the percentage born in 
Australia, the percentage born outside the UK or Australia, the percentage who had 
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completed the highest year of school, and the percentage who had ever been told they had 
diabetes. Adjustment for age and gender rectified the difference between responders and 
non-responders for the percentage married, but differences were still observed in the 
percentage who suspected that they had diabetes, the percent born in the UK and the 
percentage of English speakers. Additionally, after adjustment for age and gender, the 
percentage who had completed the final year of high school, technical education or 
University was higher for responders. 
 
4. Discussion 
The Australian Diabetes, Obesity and Lifestyle Study is the largest cross-sectional study of 
the prevalence of diabetes and its precursors ever performed in a developed nation. Through 
its capacity to provide the first definitive data on the true magnitude of the diabetes epidemic 
in Australia, AusDiab will not only be a valuable resource for health care planners in 
Australia, but will also serve as an important research tool for the study of diabetes and 
associated diseases on a longitudinal basis. 
 
The AusDiab experience provides a valuable insight into the execution of population-based, 
cross-sectional surveys involving the use of an OGTT. Since AusDiab required careful 
consideration of the logistics required to achieve a national sample within the funding and 
timeframe constraints imposed, particular emphasis was given to the establishment of a 
study design that reflected the ‘best available’ model. This extensive 12-month planning 
process was crucial to the successful implementation of the study. 
 
Several aspects of the methods used in sample selection and the study design of AusDiab 
warrant further discussion. First, the inclusion criteria contained only those CDs that 
contained less than 10% indigenous population. Existing data provide clear evidence of a 
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very high prevalence of diabetes among the indigenous population in Australia [9]. To 
overcome the chance selection of one or more CDs with a large proportion of indigenous 
people, and thus minimize the potential bias introduced to the national and state diabetes 
estimates, we considered it more practical to restrict the inclusion criteria to those CDs 
likely to contain smaller proportions of indigenous people rather than account for any 
potential bias at the analysis stage. Furthermore, this approach was considered important for 
the operations of the study, since aspects such as questionnaire design would have required 
extensive modifications to reflect the cultural differences. It is unlikely that this restriction 
would have impacted greatly on the generation of national estimates since the indigenous 
population is numerically a very small minority group in Australia (approximately 2% of the 
total Australian population), and indeed, represented only 0.8% of the total AusDiab sample. 
Preparations are presently underway to address these issues through a survey that will 
employ similar survey methods used within AusDiab in urban indigenous Australians living 
in Darwin, Northern Territory.  
 
The decision to sample equal numbers from each stratum reflects a compromise between the 
primary and secondary objectives of the survey. It is probable that a study design that 
sampled from the states proportional to their size would have been more efficient in terms of 
providing a more accurate national diabetes prevalence estimate, however accurate estimates 
for all states (in particular the smaller states) would have been compromised. Since 
weighting of the data prior to the analysis stage enables us to allow for over-representation 
of the smaller states and under-representation of the larger states, it is unlikely that our 
primary objective was compromised unduly by this decision. 
 
It is also noted that, due to the exclusion criteria of the study, the results may not be 
generalisable to either the indigenous population or the rural population of Australia. The 
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primary aim of the study, however, was to provide estimates which were accurate for the 
Australian population over 25 years as a whole and these exclusion criteria should not 
significantly affect that aim. 
 
The response rates to AusDiab can be interpreted in several ways. In many studies where a 
defined population is used as the sample pool, an absolute response rate can be accurately 
calculated. For example, when using an electoral role in the sample selection, the number of 
residents in each household is accurately known, allowing the demographic profile of both 
the non-responders and the responders to be calculated. In AusDiab, the sample pool was 
comprised of households in CDs based on the 1996 Australian census, conducted two years 
prior to commencement of the AusDiab survey. An accurate estimate of the number of 
residents in households where contact was not achieved, as well as the age and gender 
profile of these households cannot be accurately obtained. This is due to the possibility that 
in those households where contact could not be achieved, many may have been unoccupied, 
or the resident population in each household may be lower (assuming that the more people 
residing in a household, the more likely it is that someone will be home when an interviewer 
calls).  
 
Our estimates suggest, however, that reasonably good response rates were obtained from 
those households where contact could be achieved. Furthermore, considering the duration 
and nature of the testing procedures involved in the biomedical examination for each 
individual, the response to the biomedical examination is acceptable. Nevertheless, 
additional in-depth analyses will be necessary to explore whether specific non-response 
biases exist at both the national and state level.  
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Regarding the analysis of non-response bias presented, there are several points worth noting. 
Firstly, the difference in the percentage of English speakers between responders and non-
responders shown in table 3, while being significant, was fairly small (96.1% vs. 93.6%) and 
is unlikely to have had a significant impact on diabetes or other prevalence estimates. 
Similarly, the percentage of responders born in the UK was only slightly greater than the 
percentage of non-responders born in the UK (10.3% vs. 8.8%), although again, this 
difference was significant. Most of the difference in country of birth between responders and 
non-responders was removed by age and gender-standardisation. It is unlikely that the 
percentage of people born in the UK would have an important effect on diabetes prevalence 
estimates, since many cultural similarities exist for those born in the UK and those born in 
Australia. 
 
The greatest differences between responders and non-responders were observed in suspicion 
of diabetes and level of education. Firstly, the percentage of those who suspected they had 
diabetes (but have never been told they do) was significantly higher in the responders (1.5%) 
compared to the non-responders (0.5%).  Only one in 12 of those who suspected they had 
diabetes were actually found to have the disease, compared to one in 25 of those who did not 
suspect they had diabetes. Taking into account the very low prevalence of those who 
suspected they had diabetes, and the low prevalence of those found to actually have diabetes 
when they suspected they had diabetes, the difference between responders and non-
responders with respect to suspicion of diabetes would have increased the total number of 
newly diagnosed cases of diabetes by 6 or 7 persons at most. This would be expected to 
have only a negligible effect on the total prevalence estimates for diabetes.  
 
Participants who attended the biomedical examination were more likely to have completed 
the final year of high school, University or other higher education (58.2% vs. 51.3%) than 
Page 16  16 
non-responders. This would indicate that the higher socio-economic groups were over-
represented in AusDiab. This difference could potentially bias estimates of diabetes, as well 
as other studied variables. However, for glucose intolerance, as well as other cardiovascular 
disease risk factors such as dyslipidaemia, physical activity, alcohol consumption and 
smoking, there is a negative association with socio-economic status [10]. Therefore, our 
estimates of these disease states, if a socio-economic bias does indeed exist, are likely to 
underestimate the true prevalence. Of course, education level is only one indicator of socio-
economic status, and other variables such as income level, occupation and type of residence 
will need to be considered in further analyses of response bias. Detailed comparisons 
between responders and the Australian population aged over 25 (using both census data and 
other previous surveys), particularly in the areas of socio-economic status, language spoken 
and suspicion of diabetes, will be valuable in assessing more precisely the impact of any 
response bias in the AusDiab survey. 
 
AusDiab is a major achievement in the study of diabetes in Australia. The study not only 
provides much needed data on the current magnitude of the diabetes epidemic that exists in 
Australia but also fills a 10 year void in knowledge on current levels of many of the 
associated cardiovascular disease risk factors that can only be determined through blood 
collection. Furthermore, an important extension to this initiative will be the follow-up of the 
AusDiab cohort, that will provide the first opportunity ever in Australia to examine the 
natural history of diabetes and its complications, as well as the incidence of cardiovascular 
disease among this representative sample of Australians with diabetes or impaired glucose 
metabolism. 
 
 
 
Page 17  17 
Acknowledgements 
We are most grateful to the following for their support of the study: The Commonwealth 
Dept of Health and Aged Care, Eli Lilly (Aust) Pty Ltd, Janssen – Cilag (Aust) Pty Ltd, 
Knoll Australia Pty Ltd, Merck Lipha s.a., Alphapharm Pty Ltd, Merck Sharp & Dohme 
(Aust), Roche Diagnostics, Servier Laboratories (Aust) Pty Ltd, SmithKline Beecham 
International, Pharmacia and Upjohn Pty Ltd, BioRad Laboratories Pty Ltd, HITECH 
Pathology Pty Ltd, the Australian Kidney Foundation, Diabetes Australia (Northern 
Territory), Queensland Health, South Australian Department of Human Services, Tasmanian 
Department of Health and Human Services, Territory Health Services, Victorian Department 
of Human Services and Health Department of Western Australia.  
For their invaluable contribution to the field activities of AusDiab, we are enormously 
grateful to Annie Allman, Marita Dalton, Adam Meehan, Claire Reid, Alison Stewart, 
Robyn Tapp and Fay Wilson. 
And our special thanks goes to the local collaborating centers, including Sir Charles 
Gairdner Hospital (Western Australia), the Prince of Wales Hospital (New South Wales), 
the Menzies Centre for Population Health Research (Tasmania), the Queen Elizabeth 
Hospital (South Australia), the Menzies School of Health Research (Northern Territory), 
Queensland Health, the Monash Medical Centre, Department of Nephrology (Victoria) and 
the Centre for Eye Research Australia (Victoria). 
 
References 
 
1. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its 
complications: Estimates and projections to the year 2010. Diabetic Med. 1997;14:S1-
S85. 
Page 18  18 
2. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025. Prevalence, 
numerical estimates and projections. Diabetes Care. 1998;21:1414-1431. 
3. Harris M, Glegal K, Cowie C, et al. Prevalence of impaired fasting glucose, and 
impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition 
Examination 1988-1994. Diabetes Care. 1998;21:518-524. 
4. Glatthaar C, Welborn TA, Stenhouse NS, Garcia-Webb P. Diabetes and impaired 
glucose tolerance. A prevalence estimate based on the Busselton 1981 survey. Med J 
Aust. 1985;143:436-440. 
5. World Health Organisation. Diabetes and Noncommunicable Disease Risk Factor 
Surveys - A Field Guide. Geneva: World Health Organisation; 1999. 
6. Australian Bureau of Statistics. Census of Population and Housing: CDATA96, 
Australia Cat. No. 2019.0.30.001. Canberra: Australian Bureau of Statistics; 1997. 
7. Dowse G, Zimmet P. A model protocol for a diabetes and other noncommunicable 
disease field survey. Wld Hlth Statist Quart. 1992;45:360-372. 
8. Australian Bureau of Statistics. Population by Age and Sex, Australian States and 
Territories. Canberra: Australian Bureau of Statistics; 1999. 
9. O'Dea K. Westernisation, insulin resistance and diabetes in Australian Aborigines. 
Med J Aust. 1991;155:258-264. 
10. Brunner E, Shipley M, Blane D, Smith G, Marmot M. When does cardiovascular risk 
start? Past and present socioeconomic circumstances and risk factors in adulthood. J 
Epi Comm Hlth. 1999;53:757-764. 
 
Page 19  19 
Table 1 - Variables assessed within AusDiab 
 
Category Variable Measurement Instrument 
Demographic characteristics • Age, sex, ethnicity 
• Socio-economic status (education, 
occupation, income) 
• Diabetes status 
Household interview 
& 
Interviewer-administered 
questionnaires at survey site 
 
Medical and family history • Family history (diabetes) 
• Chronic health conditions 
(cardiovascular disease, gout) 
• Women's health 
 
Interviewer-administered 
questionnaires at survey site 
 
Life-style related factors 
 
• General health & well-being 
 
• Alcohol/tobacco 
• Physical activity 
 
 
• Diet 
SF-36 Questionnaire 
 
Interviewer-administered 
questionnaires at survey site 
 
Anti-Cancer Council of Victoria 
Dietary Questionnaire (self-
administered) 
Health-behaviour related 
Factors 
 
• Health knowledge, attitudes and 
practice data 
• Health service utilisation patterns 
Interviewer-administered 
questionnaires at survey site 
Physical measurements • Height 
• Weight 
• Waist & hip circumference 
• Body fat determination 
• Blood pressure 
 
• 12-lead ECG 
Stadiometer 
Beam balance scales 
Tape measure 
Bioimpedance 
Dinamap / mercury 
sphygmomanometer 
Blood measurements 
(fasting) 
• Blood Glucose 
• Blood Lipids 
 
• HbA1c 
Glucose Oxidase 
Enzymatically - Olympus AU600 
analyser 
Boronate affinity high 
performance liquid 
chromatography (HPLC) 
Urine measurements 
(spot morning sample) 
• Albumin 
 
 
• Creatinine 
 
 
Immunoturbidimetric method - 
Olympus AU600 analyser 
 
Olympus AU600 analyser 
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Table 2 - Response rates of eligible residents to the biomedical examination by 
State/Territory 
State / 
Territory* 
Eligible residents 
(n) 
Respondents to 
household interview 
(n) 
Respondents to 
biomedical 
examination (n) 
Biomedical 
examination 
response rate (%)# 
VIC 2,396 2,391 1,434 59.8 
WA 2,527 2,485 1,561 61.8 
NSW 2,719 2,717 1,515 55.7 
TAS 3,339 3,339 1,848 55.3 
SA 3,618 3,618 1,796 49.6 
NT 2,446 2,446 1,459 59.6 
QLD 3,302 3,297 1,634 49.5 
Total 20,347 20,293 11,247 55.3 
 
• * VIC=Victoria, WA=Western Australia, NSW=New South Wales, TAS=Tasmania, SA=South Australia, 
NT=Northern Territory, QLD=Queensland 
# Calculated as biomedical examination responders as a percentage of eligible residents 
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Table 3 - Response rates of eligible residents to the biomedical examination by age and gender. 
Age/Gender 
group 
Eligible 
residents (n)* 
Respondents to household 
interview (n)* 
Respondents to biomedical 
examination (n)* 
Biomedical examination 
response rate (%)# 
Male 25-34 1757 1747 590 33.6 
Male 35-44 2342 2331 1093 46.7 
Male 45-54 2290 2281 1345 58.7 
Male 55-64 1516 1515 928 61.2 
Male 65-74 1125 1122 731 65.0 
Male 75+ 677 677 362 53.5 
Female 25-34 1894 1890 803 42.4 
Female 35-44 2510 2503 1465 58.4 
Female 45-54 2355 2352 1546 65.6 
Female 55-64 1649 1647 1096 66.5 
Female 65-74 1286 1285 837 65.1 
Female 75+ 927 927 451 48.7 
 
* NOTE – 19 eligible people refused to give their age and are thus missing from this table, of whom 16 were respondents to the 
household interview, and none were respondents to the biomedical examination. 
# Calculated as biomedical examination responders as a percentage of eligible residents 
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Table 4 - Comparison between biomedical examination responders and non-responders, both unweighted, and age and gender-adjusted to the 
1998 estimated residential population aged over 25 years. Estimates are percentages (95% CI). 
 
Characteristic 
Responders to 
biomedical exam. 
(unweighted) 
Non-responders to 
biomedical exam. 
(unweighted) 
Responders (age & 
gender adjusted to 1998 
populationa) 
Non-responders (age & 
gender adjusted to 1998 
populationa) 
Married 71.5 (68.8 - 74.2) 67.0 (64.4 - 69.5) 68.5 (65.5 - 71.5) 67.6 (65.0 - 70.2) 
Country of Birth: Australia 76.0 (72.9 - 79.1) 77.1 (73.8 - 80.5) 77.6 (74.6 - 80.6) 76.7 (73.3 - 80.1) 
Country of Birth: U.K. 11.3 (9.7 - 12.8) 8.7 (7.2 - 10.2) 10.3 (8.9 - 11.7) 8.8 (7.3 - 10.4) 
Country of Birth: Other 12.7 (10.2 - 15.2) 14.1 (10.9 - 17.3) 12.1 (9.7 - 14.5) 14.4 (11.1 - 17.7) 
Language Spoken: English 96.0 (94.6 - 97.4) 93.7 (91.2 - 96.3) 96.1 (94.9 - 97.4) 93.6 (91.0 - 96.2) 
Education: completed high 
school/University/technical education 
55.8 (51.4 - 60.1) 51.7 (46.4 - 57.1) 58.2 (54.0 - 62.4) 51.3 (46.0 - 56.6) 
Ever Told have DM? 6.4 (5.7 - 7.1) 6.2 (5.2 - 7.1) 5.9 (5.3 - 6.5) 6.4 (5.4 - 7.3) 
Suspect have DM? 1.5 (1.3 - 1.7) 0.5 (0.4 - 0.7) 1.5 (1.3 - 1.7) 0.5 (0.4 - 0.7) 
a June 30, 1998 Australian Population [8] 
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Figure 1 - Flowchart of Households and persons selected to participate in AusDiab. 
 
All Selected Dwellings = 28,033 
Non-residential + non-
occupied = 2,049 
Private Dwelling = 25,984 
Non-contact = 6,769 
Contact = 19,215 
Eligible Household = 17,129 Ineligible Household = 2,086 
Participate in HH Interview = 11,479 Refuse HH Interview = 5,178 Away Duration = 472 
Eligible People = 20,347 
Participate in HH Interview = 20,293 Refuse HH Interview = 54 
Agreed to attend for Biomedical Exam. = 15,178 
Attended Biomedical Examination = 11,247* 
Refuse Biomedical Exam. = 5,115 
Failed to attend Biomedical Examination = 3,934 
PEOPLE 
HOUSEHOLDS 
*3 people undertook biomedical examination without having completed a household 
interview. 
